| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Science Officer | Chief Scientific Officer
1 company
Kirson Eilon D. is a Chief Science Officer at NovoCure Ltd. Recent SEC Form 4 filings include 0 buys and 17 sells.
Estimated insider holdings value: $2.3M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jan 17, 2019 | NVCR Novocure Ltd | Chief Science Officer | Sale+OE | 168,813 | $45.17 | $7,624,788.25 | -43.6% | |
| Jun 4, 2018 | NVCR Novocure Ltd | Chief Science Officer | Sale+OE | 346,161 | $28.90 | $10,003,513.78 | -68.1% | |
| Apr 18, 2018 | NVCR Novocure Ltd | Chief Science Officer | Sale+OE | 147,825 | $24.00 | $3,547,800.00 | -65.1% | |
| Jan 11, 2018 | NVCR Novocure Ltd | Chief Science Officer | Sell | 25,320 | $22.00 | $557,126.09 | -88.8% | |
| Nov 6, 2017 | NVCR Novocure Ltd | Chief Science Officer | Sell | 9,100 | $22.00 | $200,200.00 | -24.2% | |
| Nov 3, 2017 | NVCR Novocure Ltd | Chief Science Officer | Sell | 3,400 | $22.00 | $74,800.00 | -4.2% | |
| Nov 1, 2017 | NVCR Novocure Ltd | Chief Science Officer | Sell | 22,269 | $22.01 | $490,110.44 | -17.6% | |
| Jun 21, 2017 | NVCR Novocure Ltd | Chief Science Officer | Sell | 66,361 | $16.78 | $1,113,205.78 | -23.0% | |
| Jun 19, 2017 | NVCR Novocure Ltd | Chief Science Officer | Sell | 15,000 | $15.06 | $225,885.00 | -4.9% | |
| Jun 13, 2017 | NVCR Novocure Ltd | Chief Science Officer | Sell | 9,044 | $15.01 | $135,768.53 | -2.9% |